Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis
Muscle Loss Is Common and Dangerous Rapid weight loss without adequate metabolic support often leads to loss of lean body mass , especially during GLP-1assisted weight loss
It has undergone a lot of clinical testing (the STEP trial program included more than 4,500 people) that shows it works and is safe, which supports regulatory submissions in big countries

however, it was associated with the highest rate of gastrointestinal adverse events ( A systematic review and meta-analysis conducted to investigate the efficacy of tirzepatide on glycated hemoglobin, fasting serum glucose, and body weight in patients with uncontrolled T2DM reported that tirzepatide significantly improved glycemic control and body weight with an acceptable safety profile ( The FDA has approved liraglutide (a maintenance dose of 3 mg injected daily), subcutaneous semaglutide (2.4 mg injected once weekly), and tirzepatide (515 mg injected once weekly) for chronic weight management in adults with body mass index (BMI) of 30 kg/m 2 or greater, or with a BMI of 27 kg/m 2 or greater with at least one weight-related condition (such as high BP, T2DM, or high cholesterol) to be used in addition to a reduced calorie diet and increased physical activity ( Overall, robust findings have showed that GLP-1 RAs effectively promote weight loss

This is very important because temperature has a significant impact on the result
For libido enhancement, start with 0.5 mg daily for the first week, then increase to 1-1.5 mg daily